Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/18600
Title: Decreased expression of mGluR5 within the dorsolateral prefrontal cortex in autism and increased microglial number in mGluR5 knockout mice: Pathophysiological and neurobehavioral implications.
Authors: Chana, Gursharan;Laskaris, Liliana;Pantelis, Christos;Gillett, Piers;Testa, Renee;Zantomio, Daniela;Burrows, Emma L;Hannan, Anthony J;Everall, Ian P;Skafidas, Efstratios
Affiliation: Department of Psychiatry, The University of Melbourne, Parkville, Victoria, Australia
Florey Institute of Neuroscience and Mental Health, University of Melbourne Parkville, Victoria, Australia
Department of Anatomy and Neuroscience, University of Melbourne, Parkville, Victoria, Australia
Centre for Neural Engineering, The University of Melbourne, Parkville, Victoria, Australia
Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne & Melbourne Health, Parkville, Victoria, Australia
Department of Psychology, Monash University, Clayton, Victoria, Australia
Department of Haematology, Austin Health, Heidelberg, Victoria, Australia
Issue Date: Oct-2015
EDate: 2015-06-05
Citation: Brain, behavior, and immunity 2015; 49: 197-205
Abstract: Metabotropic glutamate receptor 5 (mGluR5) and microglial abnormalities have been implicated in autism spectrum disorder (ASD). However, controversy exists as to whether the receptor is down or upregulated in functioning in ASD. In addition, whilst activation of mGluR5 has been shown to attenuate microglial activation, its role in maintaining microglial homeostasis during development has not been investigated. We utilised published microarray data from the dorsolateral prefrontal cortex (DLPFC) of control (n=30) and ASD (n=27) individuals to carry out regression analysis to assess gene expression of mGluR5 downstream signalling elements. We then conducted a post-mortem brain stereological investigation of the DLPFC, to estimate the proportion of mGluR5-positive neurons and glia. Finally, we carried out stereological investigation into numbers of microglia in mGluR5 knockout mice, relative to wildtype littermates, together with assessment of changes in microglial somal size, as an indicator of activation status. We found that gene expression of mGluR5 was significantly decreased in ASD versus controls (p=0.018) as well as downstream elements SHANK3 (p=0.005) and PLCB1 (p=0.009) but that the pro-inflammatory marker NOS2 was increased (p=0.047). Intensity of staining of mGluR5-positive neurons was also significantly decreased in ASD versus controls (p=0.016). Microglial density was significantly increased in mGluR5 knockout animals versus wildtype controls (p=0.011). Our findings provide evidence for decreased expression of mGluR5 and its signalling components representing a key pathophysiological hallmark in ASD with implications for the regulation of microglial number and activation during development. This is important in the context of microglia being considered to play key roles in synaptic pruning during development, with preservation of appropriate connectivity relevant for normal brain functioning.
URI: http://ahro.austin.org.au/austinjspui/handle/1/18600
DOI: 10.1016/j.bbi.2015.05.009
PubMed URL: 26052099
Type: Journal Article
Research Support, Non-U.S. Gov't
Subjects: Autism
Glutamate
Microglia
Neuroinflammation
Neuropathology
Stereology
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.